PRA Health Sciences (PRAH) Tops Q3 EPS by 6c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts PRAH Hot Sheet
Join SI Premium – FREE
PRA Health Sciences (NASDAQ: PRAH) reported Q3 EPS of $1.13, $0.06 better than the analyst estimate of $1.07. Revenue for the quarter came in at $717.6 million versus the consensus estimate of $726.88 million.
GUIDANCE:
PRA Health Sciences sees FY2018 EPS of $4.22-$4.27, versus the consensus of $4.19. PRA Health Sciences sees FY2018 revenue of $2.87-2.92 billion, versus the consensus of $2.91 billion.
For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Becton Dickinson (BDX) Tops Q4 EPS by 8c; Offers Guidance
- Ralph Lauren (RL) Tops Q2 EPS by 41c
- Wendy's (WEN) Tops Q3 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
